Effect of traditional Chinese medicine in inhibiting obesity and inflammatory diseases by regulating gut microbiota.
10.19540/j.cnki.cjcmm.20180423.003
- Author:
Ting-Ting SANG
1
;
Cheng-Jie GUO
1
;
Dan-Dan GUO
1
;
Xing-Ya WANG
1
Author Information
1. School of Pharmacy, Zhejiang Chinese Medical University, Hangzhou 311400, China.
- Publication Type:Journal Article
- Keywords:
inflammatory bowel disease;
insulin resistance;
intestinal microbiota;
non-alcoholic fatty liver disease;
obesity;
traditional Chinese medicine;
type 2 diabetes
- From:
China Journal of Chinese Materia Medica
2018;43(16):3235-3242
- CountryChina
- Language:Chinese
-
Abstract:
Traditional Chinese medicine(TCM) has been increasingly used in the prevention and treatment of obesity and obesity-related diseases. However, its mechanism of action is not yet clear. In recent years, with the development of high-throughput sequencing technology, scientific researches have found that the disorder of gut microbiota is associated with obesity and other diseases. Furthermore, it has been found that TCM can improve the structure of gut microbiota by increasing probiotics and reducing pathogens, which play an importent role in preventing the development and progression of obesity and other diseases. This article first explores the possible association between intestinal microbiota and obesity. Then, it reviews the traditional Chinese medicine and its role in regulating intestinal microbiota for the prevention and treatment of diseases, including obesity and inflammation, insulin resistance, type 2 diabetes, non-alcoholic fatty liver disease, inflammatory bowel disease and other diseases, in theexpectation of new strategies and research direction for treating obesity and relevant diseases, and providing important guidance for further studies in this field in the future.
